All current and expired Paxlovid doses with an EUA label must be returned to the manufacturer or disposed of properly, according to the agency.
The revision comes nearly 10 months after the FDA approved Pfizer’s new drug application for Paxlovid to treat COVID-19 in adults at high -risk of severe complications, including hospitalization or death. Pharmacies and healthcare providers may now only dispense the drug with this NDA labeling.
Paxlovid is still authorized for emergency use in pediatric patients 12 and up.
Learn more here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
